Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,730Revenue $M7,380Net Margin (%)-3.4Altman Z-Score1.1
Enterprise Value $M27,756EPS $-0.1Operating Margin %-6.4Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-9.6Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %--Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow37.4y-y EBITDA Growth Rate %-105.1ROA % (ttm)-1.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,341ROIC % (ttm)6.3Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMario Gabelli 2015-03-31 Reduce-0.02%$13.22 - $18.07
($15.8)
$ 17.5711%Reduce 20.16%1,317,796
BSXDodge & Cox 2015-03-31 Reduce-0.01%$13.22 - $18.07
($15.8)
$ 17.5711%Reduce 38.43%729,460
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 17.5737%Reduce 97.34%1,184,730
BSXVanguard Health Care Fund 2014-12-31 Add0.27%$11.37 - $13.68
($12.78)
$ 17.5737%Add 16.36%59,624,800
BSXLeon Cooperman 2014-09-30 Sold Out -1.1%$11.92 - $13.29
($12.59)
$ 17.5740%Sold Out0
BSXVanguard Health Care Fund 2014-09-30 Add0.25%$11.92 - $13.29
($12.59)
$ 17.5740%Add 19.88%51,242,050
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 17.5735%Reduce 23.25%6,549,479
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 17.5735%Add 16.19%42,743,200
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 17.5749%Reduce 36.64%8,533,099
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 17.5749%Add 17.65%2,000,000
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 17.5749%Reduce 22.34%45,938,468
BSXVanguard Health Care Fund 2013-12-31 Reduce-0.06%$11.18 - $12.38
($11.82)
$ 17.5749%Reduce 3.80%36,787,000
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 17.5749%Sold Out0
BSXMario Gabelli 2013-12-31 Reduce$11.18 - $12.38
($11.82)
$ 17.5749%Reduce 1.50%2,201,305
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 17.5762%Reduce 18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 17.5762%Reduce 27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 17.5762%Reduce 15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 17.5762%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 17.5762%Reduce 69.22%18,744
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 17.57107%Reduce 96.31%624,088
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nanavaty MaulikSVP & Pres, Neuromodulation 2015-05-29Sell71,558$18.52-5.13view
Carruthers WendySVP, Human Resources 2015-05-28Sell42,281$17.91-1.9view
JOHNSON KRISTINA MDirector 2015-05-18Sell16,301$18.1-2.93view
MARIO ERNESTDirector 2015-05-18Sell50,000$18.09-2.87view
Sununu John EDirector 2015-05-14Sell10,000$17.87-1.68view
Sorenson John BradleySVP, Manuf & Sup Chn 2015-05-11Sell8,735$17.490.46view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2015-05-04Sell67,964$17.91-1.9view
Phalen Michael P.EVP & President, MedSurg 2015-03-20Sell46,085$17.94-2.06view
Pierce David ASVP and President, Endoscopy 2015-03-20Sell18,050$18-2.39view
Phalen Michael P.EVP & President, MedSurg 2015-03-16Sell30,022$17.182.27view

Quarterly/Annual Reports about BSX:

News about BSX:

Articles On GuruFocus.com
Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 
Vanguard Adds to Four of Its Largest Stakes May 04 2015 
Diamond Hill Select Fund Q4 2014 Commentary Mar 17 2015 
Boston Scientific Finally Wins Positive Nod For Watchman Heart Device In U.S. Leaving Investors Impr Mar 17 2015 
Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson (JNJ) En Feb 18 2015 
A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
Boston Scientific Lost the First Place in Innovation Dec 11 2014 
Diamond Hill Capital Comments on Boston Scientific Corp Oct 17 2014 

More From Other Websites
10 Best S&P 500 Health Care Stocks Jul 01 2015
Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 Jul 01 2015
America's top states for innovation in 2015 Jun 24 2015
Boston Scientific Initiates Global Study on Emblem S-ICD - Analyst Blog Jun 24 2015
Halftime's hottest trades today: MCD, BSX, P, & GOOGL Jun 23 2015
Great time for Boston Scientific: CEO Jun 23 2015
Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator... Jun 22 2015
Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator... Jun 22 2015
Boston Scientific Precision Spectra System Cures Pain Better - Analyst Blog Jun 15 2015
New Data Demonstrate Greater Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord... Jun 10 2015
New Data Demonstrate Greater Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord... Jun 10 2015
Boston Scientific Sends IT Staff to Customers to Devise New Product Ideas Jun 05 2015
Boston Scientific Launches The Precision Novi™ Spinal Cord Stimulator System in Europe Jun 04 2015
Boston Scientific Launches The Precision Novi™ Spinal Cord Stimulator System in Europe Jun 04 2015
Boston Scientific Stable in Core Market, Currency Woes Stay - Analyst Blog Jun 03 2015
Congressman sees better odds for Obamacare medical device tax repeal Jun 02 2015
Biotech isn't only health care bet beating market Jun 01 2015
Woman wins $100 million in transvaginal mesh case May 29 2015
Woman wins $100 million in transvaginal mesh case May 29 2015
Boston Scientific ordered to pay $100 mln in transvaginal mesh trial May 28 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK